DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. raised its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.7% in the 4th quarter, Holdings Channel reports. The firm owned 2,101,133 shares of the medical instruments supplier’s stock after purchasing an additional 35,360 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in DENTSPLY SIRONA were worth $39,880,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Nordea Investment Management AB grew its position in shares of DENTSPLY SIRONA by 245.0% during the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock valued at $4,754,000 after buying an additional 178,639 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after acquiring an additional 1,244,326 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of DENTSPLY SIRONA by 27.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after purchasing an additional 523,692 shares during the last quarter. Barclays PLC raised its position in shares of DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock worth $8,301,000 after purchasing an additional 54,920 shares during the period. Finally, Canvas Wealth Advisors LLC lifted its holdings in shares of DENTSPLY SIRONA by 126.5% in the 4th quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock worth $6,245,000 after purchasing an additional 182,234 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

XRAY has been the subject of a number of recent research reports. Evercore ISI restated an “in-line” rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Mizuho lowered their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Finally, Barrington Research dropped their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $23.33.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction dated Monday, March 3rd. The shares were bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $15.56 on Friday. The firm has a market capitalization of $3.10 billion, a PE ratio of -7.52, a P/E/G ratio of 1.80 and a beta of 0.98. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a 12 month low of $14.77 and a 12 month high of $33.72. The company’s 50 day simple moving average is $18.22 and its 200 day simple moving average is $20.83.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.11%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.